HomeIMNM • NASDAQ
add
Immunome Inc
Previous close
$14.26
Day range
$13.70 - $14.39
Year range
$4.44 - $30.96
Market cap
819.60M USD
Avg Volume
710.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 3.83M | — |
Operating expense | 8.08M | 125.97% |
Net income | -92.63M | -1,089.75% |
Net profit margin | -2.42K | — |
Earnings per share | -0.15 | — |
EBITDA | -13.70M | -78.11% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 142.15M | 599.46% |
Total assets | 148.54M | 517.73% |
Total liabilities | 28.66M | 287.64% |
Total equity | 119.88M | — |
Shares outstanding | 59.69M | — |
Price to book | 5.15 | — |
Return on assets | -28.65% | — |
Return on capital | -54.12% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -92.63M | -1,089.75% |
Cash from operations | -17.46M | -161.24% |
Cash from investing | -30.00M | -41,569.44% |
Cash from financing | 55.50M | — |
Net change in cash | 8.04M | 218.99% |
Free cash flow | -9.34M | -154.53% |
About
Founded
2006
Headquarters
Website
Employees
55